Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (KCT0012715) titled 'An exploratory Clinical Study Evaluating the Effects of L. rhamnosus LDTM7511 and L. plantarum CKDB008 on Symptoms of Diarrhea-Predominant Irritable Bowel Syndrome' on Oct. 1.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Bestian Seoul Hospital
Condition:
Diseases of the digestive system
Intervention:
Dietary Supplement : Investigational Product I: L. rhamnosus LDTM7511 1.6 billion CFU/day (Take one capsule twice daily for 8 weeks.)
Investigation...